CH223191A
(de)
|
1942-05-28 |
1942-08-31 |
Ramel Otto |
Vorrichtung zum Betätigen der Bremsen an Fahrrädern.
|
US2993931A
(en)
|
1958-12-26 |
1961-07-25 |
Texaco Inc |
Process for preparing urea and an aromatic amine
|
US2997422A
(en)
|
1959-01-09 |
1961-08-22 |
Smith Kline French Lab |
Monoamine oxidase inhibition
|
US3011945A
(en)
|
1960-03-07 |
1961-12-05 |
Smith Kline French Lab |
Phenylcyclopropylamine -10-(omega-aminoalkyl)-phenothiazine ataractic composition
|
US3079403A
(en)
|
1960-09-19 |
1963-02-26 |
Smith Kline French Lab |
Process for preparing amines
|
US3134676A
(en)
|
1961-06-21 |
1964-05-26 |
Smith Kline French Lab |
Animal feed compositions and methods for their administration
|
US3244596A
(en)
|
1962-10-18 |
1966-04-05 |
Univ Iowa College Of Pharmacy |
Coated medicinal agents and coating compositions therefor
|
JPS60149520A
(ja)
|
1984-01-13 |
1985-08-07 |
Ajinomoto Co Inc |
抗腫瘍剤
|
JPS61176523A
(ja)
|
1985-01-30 |
1986-08-08 |
Teruhiko Beppu |
制癌剤
|
JPH01224381A
(ja)
|
1988-03-04 |
1989-09-07 |
Japan Tobacco Inc |
トリコスタチン酸、トリコスタチンaの新規な合成中間体、及びトリコスタチン酸、トリコスタチンaの製造方法。
|
GB8817743D0
(en)
|
1988-07-26 |
1988-09-01 |
Fujisawa Pharmaceutical Co |
Fr901228 substance & preparation thereof
|
US5571714A
(en)
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
US6124449A
(en)
|
1990-06-11 |
2000-09-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US5731424A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
US5512421A
(en)
|
1991-02-19 |
1996-04-30 |
The Regents Of The University Of California |
Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
DK0669836T3
(da)
|
1992-11-13 |
1996-10-14 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom
|
ZA945363B
(en)
|
1993-07-21 |
1995-03-14 |
Smithkline Beecham Corp |
Novel compounds
|
ES2140561T3
(es)
|
1993-09-17 |
2000-03-01 |
Smithkline Beecham Corp |
Proteina de union de farmacos.
|
US5426196A
(en)
|
1993-12-22 |
1995-06-20 |
Glaxo Inc. |
Synthesis of diaryl methanes
|
JPH07206670A
(ja)
|
1994-01-14 |
1995-08-08 |
Kyowa Hakko Kogyo Co Ltd |
免疫抑制剤
|
US5486534A
(en)
|
1994-07-21 |
1996-01-23 |
G. D. Searle & Co. |
3,4-substituted pyrazoles for the treatment of inflammation
|
US5547892A
(en)
|
1995-04-27 |
1996-08-20 |
Taiwan Semiconductor Manufacturing Company |
Process for forming stacked contacts and metal contacts on static random access memory having thin film transistors
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
CA2232090A1
(en)
|
1995-09-21 |
1997-03-27 |
Eli Lilly And Company |
Selective .beta.3 adrenergic agonists
|
ZA967892B
(en)
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
GB2306108A
(en)
|
1995-10-13 |
1997-04-30 |
Merck & Co Inc |
Treatment of Raf-mediated cancers with imidazole derivatives
|
JP2000506532A
(ja)
|
1996-03-13 |
2000-05-30 |
スミスクライン・ビーチャム・コーポレイション |
サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物
|
JP2000507545A
(ja)
|
1996-03-25 |
2000-06-20 |
スミスクライン・ビーチャム・コーポレイション |
Cns損傷についての新規な治療
|
US6281230B1
(en)
|
1996-07-24 |
2001-08-28 |
Celgene Corporation |
Isoindolines, method of use, and pharmaceutical compositions
|
US5798368A
(en)
|
1996-08-22 |
1998-08-25 |
Celgene Corporation |
Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levels
|
EP0827946A1
(en)
|
1996-09-04 |
1998-03-11 |
Vrije Universiteit Brussel |
Inhibitors for the differentiation of cells, in particular hepatic stellate cells
|
DE69711519T2
(de)
|
1996-09-05 |
2002-10-31 |
Eli Lilly And Co., Indianapolis |
Carbazolanaloge als selektive beta3-adrenergische Agonisten
|
TW589189B
(en)
|
1997-08-04 |
2004-06-01 |
Scras |
Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
|
US5955476A
(en)
|
1997-11-18 |
1999-09-21 |
Celgene Corporation |
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
|
US6806358B1
(en)
|
1997-12-16 |
2004-10-19 |
University Of California San Diego |
Peptide inhibitor of TGF-β growth factors
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
CA2321307A1
(en)
|
1998-02-27 |
1999-09-02 |
Venkatachala L. Narayanan |
Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
|
FR2778337B1
(fr)
|
1998-05-05 |
2001-08-31 |
Inst Nat Sante Rech Med |
Antagonistes des ligands du recepteur des arylhydrocarbures
|
GB9809869D0
(en)
|
1998-05-09 |
1998-07-08 |
Medical Res Council |
Inhibition of protein kinases
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
US6489344B1
(en)
|
1998-06-19 |
2002-12-03 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
GB9827152D0
(en)
|
1998-07-03 |
1999-02-03 |
Devgen Nv |
Characterisation of gene function using double stranded rna inhibition
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
ES2146552B1
(es)
|
1998-11-24 |
2001-04-16 |
Inst Cientifico Tecnol Navarra |
Peptidos inhibidores de tgf/31
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
WO2000059900A1
(en)
|
1999-04-01 |
2000-10-12 |
The Board Of Trustees Of The University Of Arkansas |
P38mapk inhibitor and uses thereof
|
MXPA01011499A
(es)
|
1999-05-13 |
2002-06-04 |
American Cyanamid Co |
Formulaciones de combinacion de adyuvantes.
|
AU1086501A
(en)
|
1999-10-15 |
2001-04-30 |
Carnegie Institution Of Washington |
Rna interference pathway genes as tools for targeted genetic interference
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
EP1276889B1
(de)
|
2000-04-27 |
2005-10-19 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Sleeping beauty, ein transposonvektor mit breitem wirtsbereich für die genetische transformation bei wirbeltieren
|
EP1313872A1
(en)
|
2000-09-01 |
2003-05-28 |
Fujisawa Pharmaceutical Co., Ltd. |
A method of producing fr901228
|
WO2002020495A2
(en)
|
2000-09-06 |
2002-03-14 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
US6509318B1
(en)
|
2000-09-29 |
2003-01-21 |
The Regents Of The University Of California |
TGF-B inhibitors and methods
|
US7399633B2
(en)
|
2000-10-27 |
2008-07-15 |
Fred Hutchinson Cancer Research Center |
Methods for immortalizing cells
|
GB0102672D0
(en)
|
2001-02-02 |
2001-03-21 |
Glaxo Group Ltd |
Compounds
|
US20050287128A1
(en)
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
US20050227936A1
(en)
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
CA2446820C
(en)
|
2001-05-24 |
2010-07-13 |
Eli Lilly And Company |
Novel pyrrole derivatives as pharmaceutical agents
|
US20030028905A1
(en)
|
2001-07-31 |
2003-02-06 |
Petra Knaus |
Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
|
JP5170934B2
(ja)
|
2001-08-16 |
2013-03-27 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
改良dnaリポフェクションならびに/または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
|
JP2005504770A
(ja)
|
2001-08-17 |
2005-02-17 |
メルク エンド カムパニー インコーポレーテッド |
5−スルホンアミド−8−ヒドロキシ−1,6−ナフチリジン−7−カルボキサミドの製造方法
|
US20040006030A1
(en)
|
2002-07-02 |
2004-01-08 |
Isis Pharmaceuticals Inc. |
Antisense modulation of TGF-beta 2 expression
|
JP2005530800A
(ja)
|
2002-05-15 |
2005-10-13 |
スミスクライン・ビーチャム・コーポレイション |
ベンゾオキサジンおよびベンゾオキサジノン置換トリアゾール
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
US20050245520A1
(en)
|
2002-07-31 |
2005-11-03 |
Nerina Dodic |
2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
|
AP2005003262A0
(en)
|
2002-09-18 |
2005-03-31 |
Pfizer Prod Inc |
Novel isothiazole and isoxazole compounds as tranforming growth factor (TGF) inhibitors.
|
DE60330362D1
(de)
|
2002-09-18 |
2010-01-14 |
Pfizer Prod Inc |
Neue pyrazol-verbindungen als hemmer des transformierenden wachstumsfaktors (tgf)
|
AU2003268155A1
(en)
|
2002-09-19 |
2004-04-08 |
Eli Lilly And Company |
Methods of inhibiting tgf beta with substituted pyrazoles
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
US20040138188A1
(en)
|
2002-11-22 |
2004-07-15 |
Higgins Linda S. |
Use of TGF-beta inhibitors to counteract pathologic changes in the level or function of steroid/thyroid receptors
|
WO2004067530A1
(en)
|
2003-01-27 |
2004-08-12 |
Pfizer Products Inc. |
Isothiazole derivatives
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
ES2305744T3
(es)
|
2003-03-12 |
2008-11-01 |
Millennium Pharmaceuticals, Inc. |
Derivados de quinazolina como inhibidores e tgf-beta.
|
WO2004087056A2
(en)
|
2003-03-28 |
2004-10-14 |
Scios Inc. |
BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
|
WO2004087646A2
(de)
|
2003-04-03 |
2004-10-14 |
Merck Patent Gmbh |
Pyrrolidin -1,2-dicarbonsäure-1-(phenylamid) -2- (4-(3-oxo-morpholin-4-yl)-phenylamid) derivate und verwandte verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen
|
US7575822B2
(en)
|
2003-04-09 |
2009-08-18 |
Bloom Energy Corporation |
Method of optimizing operating efficiency of fuel cells
|
US7314939B2
(en)
|
2003-06-17 |
2008-01-01 |
Millennium Pharmaceuticals, Inc. |
Compositions and methods for inhibiting TGF-β
|
JP4723799B2
(ja)
|
2003-07-08 |
2011-07-13 |
株式会社ソニー・コンピュータエンタテインメント |
制御システムおよび制御方法
|
US20060229266A1
(en)
|
2003-08-13 |
2006-10-12 |
Kumar Nalin M |
Silencing of tgf-beta receptor type II expression by sirna
|
FR2860514A1
(fr)
|
2003-10-03 |
2005-04-08 |
Sanofi Synthelabo |
Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
|
JP4688680B2
(ja)
|
2003-10-28 |
2011-05-25 |
独立行政法人理化学研究所 |
TGF−β情報伝達経路阻害剤
|
US7368445B2
(en)
|
2004-03-01 |
2008-05-06 |
Eli Lilly And Company |
Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
FR2873498B1
(fr)
|
2004-07-20 |
2007-08-10 |
Conception & Dev Michelin Sa |
Arret d'une pile a combustible alimentee en oxygene pur
|
JP2007176795A
(ja)
|
2004-08-18 |
2007-07-12 |
Univ Nihon |
TGF−β遺伝子発現抑制剤
|
DE102004047254A1
(de)
|
2004-09-29 |
2006-04-13 |
Merck Patent Gmbh |
Carbonylverbindungen
|
US7850960B2
(en)
|
2004-12-30 |
2010-12-14 |
University Of Washington |
Methods for regulation of stem cells
|
CN101189234B
(zh)
|
2005-03-25 |
2011-08-17 |
泰博特克药品有限公司 |
Hcv的杂二环抑制剂
|
US20080207594A1
(en)
|
2005-05-04 |
2008-08-28 |
Davelogen Aktiengesellschaft |
Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
|
PT1910370E
(pt)
|
2005-07-22 |
2015-06-30 |
Lilly Co Eli |
Um pirrolo[1,2-b]pirazole mono-hidratado substituído com piridina e quinolina como inibidor do tgf-beta
|
US20080194021A1
(en)
|
2005-07-29 |
2008-08-14 |
Mays Robert W |
Use of a Gsk-3 Inhibitor to Maintain Potency of Culture Cells
|
WO2007039151A1
(en)
|
2005-09-28 |
2007-04-12 |
Universität Zürich |
Blockers of transforming growth factor beta and its receptors for the treatment of infectious diseases
|
EP2341135A3
(en)
|
2005-10-18 |
2011-10-12 |
Precision Biosciences |
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
|
CN101340927A
(zh)
|
2005-10-24 |
2009-01-07 |
西玛生物医学信息公司 |
TGF-β1抑制性多肽在制备免疫反应调节剂上的用途
|
KR100998816B1
(ko)
|
2005-10-31 |
2010-12-06 |
주식회사 대웅제약 |
신규한 항진균성 트리아졸 유도체
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
KR20080082618A
(ko)
|
2005-12-16 |
2008-09-11 |
알콘, 인코퍼레이티드 |
Alk5 조절제를 사용한 안압의 조절
|
WO2007075911A2
(en)
|
2005-12-22 |
2007-07-05 |
Yale University |
Inhibition of glycogen synthase kinase and methods of treating autoimmune or immune inflammatory disease
|
KR20070077468A
(ko)
|
2006-01-23 |
2007-07-26 |
크리스탈지노믹스(주) |
단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물
|
US20090186076A1
(en)
|
2006-02-01 |
2009-07-23 |
Kazunori Kataoka |
Combined Use of TGF-Beta Signaling Inhibitor and Antitumor Agent
|
ITMI20060181A1
(it)
|
2006-02-03 |
2007-08-04 |
Univ Padova |
Modulatori del tgf-b e loro uso
|
WO2007109097A2
(en)
|
2006-03-16 |
2007-09-27 |
Alnylam Pharmaceuticals, Inc. |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
|
AU2007230902B2
(en)
|
2006-03-24 |
2013-03-14 |
Children's Medical Center Corporation |
Method to modulate hematopoietic stem cell growth
|
WO2008022182A1
(en)
|
2006-08-16 |
2008-02-21 |
The Uab Research Foundation |
Methods for promoting coupling between bone formation and resorption
|
EP1995316A1
(de)
|
2007-05-25 |
2008-11-26 |
Qiagen GmbH |
Verfahren zur schonenden Zellaufreinigung, Zellgewinnung und Transfektion von Zellen
|
EP2009095A1
(en)
|
2007-06-28 |
2008-12-31 |
Innovalor AG |
Method of generating glucose-responsive cells
|
US20110190280A1
(en)
|
2007-08-29 |
2011-08-04 |
George Adjabeng |
Thiazole And Oxazole Kinase Inhibitors
|
CA2704383A1
(en)
|
2007-10-31 |
2009-05-07 |
James Jefferson Smith |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
GB0805312D0
(en)
|
2008-03-20 |
2008-04-30 |
Medical Res Council |
Modulation of the immune response
|
FR2932180B1
(fr)
|
2008-06-04 |
2012-08-10 |
Centre Nat Rech Scient |
Dihydro iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de la polymerisation de la tubuline
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
GB0818907D0
(en)
|
2008-10-15 |
2008-11-19 |
Isis Innovation |
Histone lysine demethylase inhibitors
|
WO2010065917A1
(en)
|
2008-12-05 |
2010-06-10 |
The Regents Of The University Of California |
Methods of treating neurological disorders
|
SG172160A1
(en)
|
2008-12-17 |
2011-07-28 |
Scripps Research Inst |
Generation and maintenance of stem cells
|
WO2010085699A2
(en)
|
2009-01-23 |
2010-07-29 |
The Johns Hopkins University |
Mammalian piggybac transposon and methods of use
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
US8822684B1
(en)
|
2009-08-06 |
2014-09-02 |
Vanderbilt University |
Compounds and methods useful for directing stem cell differentiation
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
CA2804795A1
(en)
|
2010-07-12 |
2012-01-19 |
Nicholas Vrolijk |
Romidepsin solid forms and uses thereof
|
WO2012107499A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
WO2012109429A2
(en)
|
2011-02-09 |
2012-08-16 |
Glaxosmithkline Llc |
Lyophilized formulations
|
WO2012115120A1
(ja)
|
2011-02-21 |
2012-08-30 |
国立大学法人 大阪大学 |
5-ht神経細胞の製造方法
|
WO2012122405A2
(en)
|
2011-03-08 |
2012-09-13 |
The Trustees Of Columbia University In The City Of New York |
Screening assays using stem cells and stem cell-derived neurons from mouse models of alzheimer's disease
|
RU2456356C1
(ru)
|
2011-04-29 |
2012-07-20 |
Борис Сергеевич Кустов |
Коллоидный раствор наносеребра и способ его получения
|
US9505763B2
(en)
|
2011-07-25 |
2016-11-29 |
Vanderbilt University |
Cancer treatment using BMP inhibitor
|
EP2763670B1
(en)
|
2011-10-03 |
2018-12-05 |
Universite Libre De Bruxelles |
Reactivation of hiv-1 gene expression to treat persistent hiv infection
|
US8735622B2
(en)
|
2011-11-30 |
2014-05-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Histone demethylase inhibitors and methods for using the same
|
US9834755B2
(en)
|
2011-12-08 |
2017-12-05 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
US20130178520A1
(en)
|
2011-12-23 |
2013-07-11 |
Duke University |
Methods of treatment using arylcyclopropylamine compounds
|
MX2014008390A
(es)
|
2012-01-12 |
2014-09-22 |
Celgene Corp |
Formulaciones de romidepsina y sus usos.
|
ES2733946T3
(es)
|
2012-01-27 |
2019-12-03 |
Univ Montreal |
Derivados de pirimido[4,5-b]indol y su uso en la expansión de células madre hematopoyéticas
|
CN104379732B
(zh)
|
2012-04-24 |
2018-08-17 |
国际干细胞公司 |
由人多能干细胞衍生神经干细胞和多巴胺能神经元
|
WO2013166488A1
(en)
|
2012-05-04 |
2013-11-07 |
Indiana University Research & Technology Corporation |
Methods for generating the inner ear and other cranial placode-derived tissues using pluripotent stem cells
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
CN103577266B
(zh)
|
2012-07-31 |
2017-06-23 |
国际商业机器公司 |
用于对现场可编程门阵列资源进行分配的方法及***
|
EP2907870A4
(en)
|
2012-10-09 |
2016-04-06 |
Hayashi Nakanobu |
REPROGRAMMING PEPTIDE AND USE THEREOF
|
WO2014062138A1
(en)
|
2012-10-19 |
2014-04-24 |
Agency For Science, Technology And Research |
Methods of differentiating stem cells into one or more cell lineages
|
US20140127231A1
(en)
|
2012-11-02 |
2014-05-08 |
University Of Vermont |
p38 MAPK Pathway Inhibitors as Female-Specific Therapeutics
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
WO2014102731A1
(en)
|
2012-12-31 |
2014-07-03 |
Leiutis Pharmaceuticals Pvt. Ltd |
Novel pharmaceutical compositions of romidepsin
|
US20140248696A1
(en)
|
2013-03-01 |
2014-09-04 |
Wisconsin Alumni Research Foundation |
Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors
|
EP2964651A4
(en)
|
2013-03-04 |
2016-11-30 |
Brigham & Womens Hospital |
BMP HEMMER AND METHOD OF USE THEREOF
|
CA2903081A1
(en)
|
2013-03-14 |
2014-09-25 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
CA2906752A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Children's Medical Center Corporation |
Compositions and methods for reprogramming hematopoietic stem cell lineages
|
AU2014256876B2
(en)
|
2013-04-26 |
2020-11-12 |
Cornell, University |
Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
|
EP3003301B1
(en)
|
2013-05-30 |
2021-02-24 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells
|
BR112015030918A2
(pt)
|
2013-06-11 |
2017-12-05 |
Astellas Pharma Inc |
método para produção de células progenitoras renais, e fármacos contendo células progenitoras renais
|
US20160116474A1
(en)
|
2013-06-20 |
2016-04-28 |
The Broad Institute, Inc. |
Compositions and methods for detecting and treating glioblastoma
|
CN104278008B
(zh)
|
2013-07-12 |
2020-08-21 |
北京宏冠再生医学科技有限公司 |
一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
|
WO2015148716A1
(en)
*
|
2014-03-26 |
2015-10-01 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells
|
US10669528B2
(en)
*
|
2015-06-25 |
2020-06-02 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
|
US20190119642A1
(en)
*
|
2016-03-15 |
2019-04-25 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion
|